AI Article Synopsis

  • The surgical treatment of laryngeal cancer often requires managing the tongue-base, which is crucial for regaining laryngeal function, but previous methods were inadequate for effective repair.
  • A new approach involves using a sternohyoid myofascial flap for reconstruction after cancer removal, with promising results in partial laryngectomy cases.
  • Out of 32 patients, 81.3% were decannulated, most regained speaking abilities, maintained normal diets without complications, and showed good long-term survival rates.

Article Abstract

Background & Objective: The surgical treatment of laryngeal cancer, especially for the supraglottic cancer, usually involve the management of tongue-base, which is important in the rebuilding laryngeal function. There was no simple and effective method to repair tongue-base previously, which was removed for the greater part when invaded by advanced laryngeal cancer. As a result, many cases could not regain the satisfactory laryngeal function. And only several published reports focused on the efficacy of rebuilding laryngeal function by means of tongue-base flap. In order to develop a simple and reliable method to rebuild the laryngeal function, the management of tongue base in surgical treatment of laryngeal cancer was explored.

Methods: After the laryngeal carcinoma or the involved tongue-base was removed, according to the extent of surgical defect, sternohyoid myofascial flap was used to reconstruct the tongue-base, or the tongue-base was selected to rebuild the laryngeal function when greater part of it was preserved.

Results: Out of the 32 cases with partial laryngectomy, 26 cases were decannulated with a decannulation rate of 81.3%, all the cases regained speaking functions except 4 cases undergone total laryngectomy. All the cases resumed normal diet, none presented complication of accidental aspiration. The 3-year and 5-year survival rates were 81.3% and 65.6%, respectively.

Conclusion: Reconstructing or pulling down the tongue-base is highly effective in rebuilding satisfactory laryngeal function, which is easily and simply performed with less damage and complications, appropriate for surgical treatment of laryngeal cancer.

Download full-text PDF

Source

Publication Analysis

Top Keywords

laryngeal function
24
surgical treatment
16
treatment laryngeal
16
laryngeal cancer
16
laryngeal
12
tongue-base
8
pulling tongue-base
8
rebuilding laryngeal
8
tongue-base removed
8
satisfactory laryngeal
8

Similar Publications

Purpose Of Review: To summarize current evidence regarding the indication of adjuvant treatment after transoral laser microsurgery (TOLMS).

Recent Findings: Apart from well known risk factors, margins represent the key point in the decision-making. If margins are affected, additional treatment is mandatory.

View Article and Find Full Text PDF

Background: Tumor-derived small extracellular vesicles (sEVs) play an essential role in reprogramming the tumor microenvironment. Metabolic reprogramming is an essential prerequisite for M2 polarization of tumor-associated macrophages (TAMs). This M2 phenotype is closely related to the immune dysfunction of CD8 T cells and subsequent tumor progression.

View Article and Find Full Text PDF

Epigenetic silencing of promotes laryngeal squamous cell carcinoma development by inhibiting the Hippo pathway.

Oncol Rep

February 2025

Department of Otolaryngology Head & Neck Surgery, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.

Laryngeal squamous cell carcinoma (LSCC), which represents a significant proportion of head and neck squamous cell carcinoma cases, is often diagnosed at advanced stages, underscoring the urgent need for effective biomarkers and therapeutic targets. Junctional adhesion molecule 3 () is implicated in various types of cancer; however, its role in LSCC remains unclear. Therefore, the present study aimed to investigate the epigenetic regulation and tumor‑suppressive functions and mechanisms of in LSCC.

View Article and Find Full Text PDF

DCUN1D5 is up-regulated and promotes tumor progression in many cancers such as laryngeal squamous cell carcinoma and breast cancer, but the expression of DCUN1D5 in lung adenocarcinoma and its molecular mechanism are not clear. The differences of DCUN1D5 expression between lung adenocarcinoma and normal tissues were compared by TCGA, GEO and UALCAN databases, and the relationship between DCUN1D5 expression and clinicopathological features of patients was analyzed. The diagnostic and prognostic value of DCUN1D5 in patients with LUAD was analyzed by TCGA, GEPIA and Kaplan-Meier Plotter database.

View Article and Find Full Text PDF
Article Synopsis
  • LINC01133 is a long non-coding RNA (lncRNA) that plays crucial roles in cancer, with this study focusing on its expression and impact in laryngeal squamous cell carcinoma (LSCC).
  • Integrative analysis of genetic data revealed LINC01133 is significantly downregulated in LSCC compared to normal tissues, and lower levels are linked to advanced tumor stages and lymph node metastasis.
  • The study suggests that LINC01133 may act as a tumor suppressor by disrupting microRNA interactions, indicating its potential diagnostic and therapeutic importance in LSCC.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!